Skip to main content
search

Early Clinical

Sign up

Latest resources

Featured resource

Upcoming early clinical webinars

Latest early clinical blogs

Meet our experts at the following events

All early clinical resources

The Power of Modeling: Speed, Early De-Risking, and Regulatory Success for Forward-Thinking Sponsors

Certara Products - Simcyp, Drug Development, ICH M15, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - QSP, New Approach Methodologies (NAMs), Webinar

Building IND-Ready and Investor-Ready Development Programs

Certara Services, Clinical Pharmacology, Drug Development, Modeling and Simulation, New Approach Methodologies (NAMs), Webinar

QSP Modeling for Parkinson’s Disease: Solving the Synthetic Control Challenge in Clinical Trials

Central Nervous System (CNS), Clinical Trials, Modeling and Simulation, Modeling and Simulation - QSP, Blog

Model Smarter, Not Harder: Introducing Model Designer

Certara Products - Phoenix, Modeling and Simulation, Modeling and Simulation - PK/PD, On-Demand Webinar

Beyond Compliance: What ICH M15 Means for the Future of Drug Development

Certara Services, Clinical Pharmacology, Drug Development, Model Informed Drug Development, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Blog

The Case for Simulating Pregnancy

Certara Products - Simcyp, Certara Services, Modeling and Simulation, Modeling and Simulation - PBPK, Press Coverage

Clinical Validation of a QSP Model for ISB 2001, a Trispecific T Cell Engager to Support Optimal FIH Study Design in RRMM Patients

Biologics, Modeling and Simulation, Modeling and Simulation - QSP, Publication

Model-Informed Development Accelerates Transformative Treatment for Sleeping Sickness

Certara Services, Rare and Neglected Diseases, Case Study

Review: application and opportunities for machine learning and artificial intelligence in preclinical immunogenicity risk assessment

Biologics, Certara Products - Certara IQ, Modeling and Simulation - QSP, Publication

Certara’s NLME Engine: Setting the Standard for Run Speed and Stability

Certara Products - Phoenix, Fact Sheet

Oxford Academic, Neuro-Oncology Pediatrics – BRAF pub: Growth recovery in patients with BRAF-altered pediatric low-grade glioma following treatment with tovorafenib

Central Nervous System (CNS), Certara Products, Certara Products - Simcyp, Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Therapeutic Specialties, Publication

The Modeling Advantage: How Forward-Thinking Sponsors Are Moving Faster, De-Risking Earlier, and Winning with Regulators

Certara Products - Certara IQ, Certara Products - Simcyp, Drug Development, Drug-Drug Interactions (DDI), ICH M15, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - QSP, New Approach Methodologies (NAMs), On-Demand Webinar
Sign up to newsletter

Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.